MD Anderson researchers highlight advances in clinical studies at the AACR Annual Meeting 2021
Early phase clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with RET fusion-positive cancers, high-grade (HGG) and low-grade glioma (LGG) and ovarian cancer.
The results, presented today at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, showcase the researchers’ ongoing efforts to advance clinical studies and expand...
